THE TREATMENT OF INVOLUTIONAL PSYCHOSES WITH DIETHYL STILBESTROL
Abstract
1. Large doses of diethyl stilbestrol were administered to 45 women with involutional psychoses.
2. Twenty-seven (60 per cent) were improved, while in a control series of 128 women, only 54 (42 per cent) were improved.
3. (A) The simple cases of involutional psychosis responded well to estrogenic therapy. (B) The cases of moderate severity and those of the mixed type reacted favorably, particularly when adjuvant therapy was employed, but relapses occurred and the degree of improvement was not as marked. (C) The psychotic manifestations in the severe cases were not materially affected. These cases may represent a different clinical entity than the mild cases. (D) Therefore, a therapeutic test with estrogenic substance may possess some diagnostic value in involutional psychoses.
4. Cases of dementia præcox, manic-depressive psychosis, and chronic psychoneurosis occurring during the involutional period were not favorably influenced by estrogenic therapy.
5. Diethyl stilbestrol administered orally was about as effective as alpha estradiol injected intramuscularly. About half of those who were given the former preparation exhibited some form of toxic reaction which for the most part did not seriously interfere with the treatment régime. Both substances produced similar psychologic effects.
6. It is concluded that adequate estrogenic therapy has a definite value in the treatment of cases of involutional psychosis of the simple type.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
